| |
 |
|
|
| |
|
THE BOARD & SENIOR MANAGEMENT
Andrew Knight
Executive Chairman
Member of Remuneration Committee
Mr Knight is a founder investor and co-founder of the
business. He is an entrepreneur with a proven commercial
track record having successfully built up a number of
private businesses. Initially involved in the development
of care homes, he expanded his business interests into
property and land development before introducing
substantial cash and resources into Henderson Morley. Mr
Knight oversees commercial aspects of the business,
together with all corporate communications. He has worked
for Henderson Morley full-time since May 2000, and he has
been instrumental in the negotiation and conclusion of
several important deals with development partners. |
|
|
|
Dr Ian Pardoe, MB ChB MRCGP
Chief Executive & Medical Director
Dr Pardoe is a co-founder of the business and a
substantial investor in the company. Dr Pardoe has been a
medical practitioner for over 20 years having worked in
the NHS and private sectors. He has been involved with the
scientific development programme since 1996, and has
considerable experience in the pre-clinical and clinical
development programmes of the company’s lead technologies.
He has been responsible for the development and management
of the intellectual property portfolio and for the
scientific research programme. He is a named inventor on
many of the company’s patents. |
|
|
|
Christopher Pate, FCA
Finance Director
Member of Audit Committee
Mr Pate is a chartered accountant and has been a Partner
in a professional firm of accountants since 1974. He was
admitted a Fellow of the Institute of Chartered
Accountants of England and Wales in 1979. He has provided
business development consultancy services to a range of
businesses throughout the West Midlands. He has experience
in industries in many diverse spheres including
engineering, distribution and property. |
|
|
|
Professor Michael Fowler, BSc Hons (Lond)
PhD (Cantab) Cbiol FIBiol FRSA Emeritus Professor of
Biotechnology in the University of Sheffield
Non-Executive Director
Member of Remuneration and Audit Committees
Professor Fowler is a past Director of the Wolfson
Institute of Biotechnology and more recently the
Department of Molecular Biology and Biotechnology at the
University of Sheffield. Professor Fowler has chaired
several committees for UNIDO (United Nations Industrial
Development Organisation) particularly in the area of
bio-diversity prospecting. He has many years of experience
as a non-executive director, and also chairs the companies
remuneration committee. |
|
|
|
Dr Christopher Hartley, Ph.D.
Principal Scientist
Dr Hartley has a PhD in virology, his thesis explored for
the first time the use and mechanism of lithium as an
anti-viral treatment. He is an authority on the ionic
basis of anti-viral chemotherapy with twenty years
experience in research into anti-viral therapy through the
development of novel vaccines and novel chemotherapies.
His contribution to the company has been the discovery of
various anti-viral treatments, diagnostic devices, patent
applications, and the successful completion of a DTI SMART
award. He has published numerous academic papers in the
field of herpes virology and anti-viral drugs. |
|
|
To send a message directly to Henderson
Morley plc,
please use this form, where you may also
optionally register an interest in taking part in clinical
trials of new products.
Henderson Morley plc
Metropolitan House
2 Salisbury Road
Moseley
Birmingham B13 8JS
Tel +44 (0) 121 442 4600
Fax +44 (0) 121 442 4611
info@henderson-morley.com
|
| |
|
 |
|
For the latest corporate announcements,
please see the
Investor relations page.
Bishopsgate Communications
2nd Floor
Henry Thomas House
5-11 Worship Street
London EC2A 2BH
Tel 0207 562 3350
Fax 0207 628 0889
investors@henderson-morley.com |
|
|
